| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |